GRI Bio GRI
NASDAQ GRI
$1.45 +0.03 (+2.11%)
At close: Oct 23, 2026 · 4:00 PM EDT

GRI Bio (GRI) Return on Sales [ROS] (2020 - 2026)

Updated

GRI Bio's Return on Sales [ROS] came in at -4786.00% for Q4 2020.

Analysis

GRI Bio (GRI) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

For FY2020, GRI Bio's Return on Sales [ROS] was -4788.00%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 24.35%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 37.86%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -3.52%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 20.57%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -133.21%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 28.37%
10 GRI Bio 2.62 Mn -31.66 Mn - -32,960.00%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -32,960.00%
Mar 31, 2026 -40,060.00%
Dec 31, 2025 -53,280.00%
Sep 30, 2025 -56,083.33%
Jun 30, 2025 -57,940.00%
Mar 31, 2025 -61,020.00%
Dec 31, 2024 -32,566.67%
Sep 30, 2024 -30,428.57%
Jun 30, 2024 -37,616.67%
Mar 31, 2024 -31,583.33%
Dec 31, 2023 -28,942.86%
Sep 30, 2023 -40,650.00%
Dec 31, 2020 -4,786.00%
Mar 31, 2020 -1,158.00%
API Access

GRI Bio Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GRI&period=max&api_key=YOUR_API_KEY